277 related articles for article (PubMed ID: 22318153)
21. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.
Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023
[TBL] [Abstract][Full Text] [Related]
22. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
Floettmann JE; Ward K; Rickinson AB; Rowe M
Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
[TBL] [Abstract][Full Text] [Related]
23. Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.
Mehl AM; Floettmann JE; Jones M; Brennan P; Rowe M
J Biol Chem; 2001 Jan; 276(2):984-92. PubMed ID: 11034993
[TBL] [Abstract][Full Text] [Related]
24. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
[TBL] [Abstract][Full Text] [Related]
25. LMP1 strain variants: biological and molecular properties.
Mainou BA; Raab-Traub N
J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
[TBL] [Abstract][Full Text] [Related]
26. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.
Pai S; O'Sullivan BJ; Cooper L; Thomas R; Khanna R
J Virol; 2002 Feb; 76(4):1914-21. PubMed ID: 11799186
[TBL] [Abstract][Full Text] [Related]
27. The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene.
Johansson P; Jansson A; Rüetschi U; Rymo L
J Virol; 2010 Mar; 84(6):2787-97. PubMed ID: 20053736
[TBL] [Abstract][Full Text] [Related]
28. Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function?
Diamantopoulos PT; Polonyfi K; Sofotasiou M; Mantzourani M; Galanopoulos A; Spanakis N; Papadopoulou V; Kalala F; Iliakis T; Zareifi DS; Kodandreopoulou E; Vassilakopoulos T; Angelopoulou M; Siakantaris M; Terpos E; Variami E; Kollia P; Vaiopoulos G; Pangalis G; Viniou NA
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):56-60. PubMed ID: 24262330
[TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1.
Hulse M; Caruso LB; Madzo J; Tan Y; Johnson S; Tempera I
PLoS Pathog; 2018 Nov; 14(11):e1007394. PubMed ID: 30395643
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.
Le Clorennec C; Ouk TS; Youlyouz-Marfak I; Panteix S; Martin CC; Rastelli J; Adriaenssens E; Zimber-Strobl U; Coll J; Feuillard J; Jayat-Vignoles C
J Virol; 2008 Jul; 82(13):6721-33. PubMed ID: 18448526
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
32. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
33. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
Edwards RH; Marquitz AR; Raab-Traub N
mBio; 2015 Apr; 6(2):. PubMed ID: 25873381
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection.
Price AM; Dai J; Bazot Q; Patel L; Nikitin PA; Djavadian R; Winter PS; Salinas CA; Barry AP; Wood KC; Johannsen EC; Letai A; Allday MJ; Luftig MA
Elife; 2017 Apr; 6():. PubMed ID: 28425914
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
Kilger E; Kieser A; Baumann M; Hammerschmidt W
EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
[TBL] [Abstract][Full Text] [Related]
37. The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection.
Wasil LR; Tomaszewski MJ; Hoji A; Rowe DT
PLoS One; 2013; 8(1):e54010. PubMed ID: 23308294
[TBL] [Abstract][Full Text] [Related]
38. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
39. High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells.
Lam N; Sandberg ML; Sugden B
J Virol; 2004 Feb; 78(4):1657-64. PubMed ID: 14747531
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
Price AM; Tourigny JP; Forte E; Salinas RE; Dave SS; Luftig MA
J Virol; 2012 Oct; 86(20):11096-106. PubMed ID: 22855490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
